Chuhe Liu

1. Morin, a novel liver X receptor α/β dual antagonist, has potent therapeutic efficacy for nonalcoholic fatty liver diseases
   2017/06/24 by Ming Gu, Yu Zhang, Chuhe Liu +8 · 12 citations
   Medicine · #Cholesterol and Lipid Metabolism #Liver Disease Diagnosis and Treatment #Diet, Metabolism, and Disease